26% of Cancer Patients Used Cannabis, Reporting Benefits for Sleep, Nausea, and Pain Despite Feeling Worse Overall

Among 267 adults undergoing cancer treatment, 26% used cannabis in the past 30 days, most commonly for pain, sleep, anxiety, and nausea, but cannabis users actually reported worse overall symptoms despite perceiving cannabis as helpful.

Azizoddin, Desiree R et al.·Cancer·2023·Moderate EvidenceCross-Sectional
RTHC-04389Cross SectionalModerate Evidence2023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
N=267

What This Study Found

Cannabis users most commonly used edibles (65%) or smoked (51%). Top medical reasons were pain, cancer itself, sleep, anxiety, nausea/vomiting, and poor appetite. Greatest perceived symptom relief was for sleep, nausea, headaches, pain, muscle spasms, and anxiety. However, cannabis users reported more severe overall symptoms and were more likely to be male, Black, disabled, lower income, and on Medicaid.

Key Numbers

267 participants; 26% past 30-day use; 4.5% screened positive for CUD; 65% used edibles; 51% smoked; greatest relief for sleep, nausea, headaches, pain; users had worse overall symptoms

How They Did This

Cross-sectional survey of 267 adults undergoing cancer treatment at an NCI-designated cancer center. Compared demographics, symptoms, cannabis use patterns, perceived benefits, and risk perceptions between past 30-day cannabis users and non-users.

Why This Research Matters

Cancer patients are using cannabis for symptom management, but the paradox that users feel worse overall suggests either that sicker patients turn to cannabis or that cannabis provides targeted symptom relief without improving global well-being. Either way, clinicians need to understand this dynamic.

The Bigger Picture

As more cancer patients explore cannabis, oncologists need guidance on what to tell them. This study suggests cannabis may help specific symptoms but does not appear to improve overall symptom burden, which tempers enthusiasm while still supporting targeted use.

What This Study Doesn't Tell Us

Cross-sectional design cannot determine whether cannabis use preceded or followed symptom severity. Selection bias: sicker patients may be more motivated to try cannabis. Self-reported perceived benefits may not reflect objective improvements. Single cancer center limits generalizability.

Questions This Raises

  • ?Does cannabis actually improve specific symptoms or do patients perceive improvement due to expectation?
  • ?Would randomized trials show the same symptom-specific benefits?
  • ?Should oncologists proactively discuss cannabis or wait for patients to ask?

Trust & Context

Key Stat:
26% used cannabis during treatment
Evidence Grade:
Cross-sectional survey at an NCI center, but cannot determine causation and subject to selection bias
Study Age:
2023 study
Original Title:
Cannabis use among adults undergoing cancer treatment.
Published In:
Cancer, 129(21), 3498-3508 (2023)
Database ID:
RTHC-04389

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Does cannabis help cancer patients feel better?

Patients reported cannabis helped specific symptoms like sleep, nausea, and pain. However, cannabis users actually reported worse overall symptoms than non-users, suggesting cannabis may provide targeted relief without improving general well-being.

How are cancer patients using cannabis?

Most commonly as edibles (65%) or smoked (51%). The top reasons were pain, the cancer itself, sleep problems, anxiety, and nausea/vomiting.

Read More on RethinkTHC

Cite This Study

RTHC-04389·https://rethinkthc.com/research/RTHC-04389

APA

Azizoddin, Desiree R; Cohn, Amy M; Ulahannan, Susanna V; Henson, Christina E; Alexander, Adam C; Moore, Kathleen N; Holman, Laura L; Boozary, Laili Kharazi; Sifat, Munjireen S; Kendzor, Darla E. (2023). Cannabis use among adults undergoing cancer treatment.. Cancer, 129(21), 3498-3508. https://doi.org/10.1002/cncr.34922

MLA

Azizoddin, Desiree R, et al. "Cannabis use among adults undergoing cancer treatment.." Cancer, 2023. https://doi.org/10.1002/cncr.34922

RethinkTHC

RethinkTHC Research Database. "Cannabis use among adults undergoing cancer treatment." RTHC-04389. Retrieved from https://rethinkthc.com/research/azizoddin-2023-cannabis-use-among-adults

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.